SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹365 Cr | ₹117 Cr | ₹303 Cr | ₹348 Cr | ₹322 Cr |
What is the latest Total Current Liabilities ratio of SUVEN PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹365 Cr |
| Mar2024 | ₹117 Cr |
| Mar2023 | ₹303 Cr |
| Mar2022 | ₹348 Cr |
| Mar2021 | ₹322 Cr |
How is Total Current Liabilities of SUVEN PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹365 Cr | 211.06 | |
| Mar2024 | ₹117 Cr | -61.27 | |
| Mar2023 | ₹303 Cr | -12.79 | |
| Mar2022 | ₹348 Cr | 8.09 | |
| Mar2021 | ₹322 Cr | - | |
Compare Total Current Liabilities of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹10,804.6 Cr | -7% | -20.9% | -75.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,704.0 Cr | 3.1% | 6.2% | 13.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,223.0 Cr | -1% | 3.3% | 14.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,928.0 Cr | -0% | 10% | 45.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,368.0 Cr | -0.6% | 3.3% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | -2% | -0.6% | -6.1% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | -7% |
-20.9% |
-75.4% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses